217 related articles for article (PubMed ID: 8260129)
1. Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations.
Borg-Stein J; Pine ZM; Miller JR; Brin MF
Am J Phys Med Rehabil; 1993 Dec; 72(6):364-8. PubMed ID: 8260129
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of spasticity with botulinum toxin].
Mémin B; Pollak P; Hommel M; Perret J
Rev Neurol (Paris); 1992; 148(3):212-4. PubMed ID: 1604136
[TBL] [Abstract][Full Text] [Related]
4. Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
Paoloni M; Giovannelli M; Mangone M; Leonardi L; Tavernese E; Di Pangrazio E; Bernetti A; Santilli V; Pozzilli C
Clin Rehabil; 2013 Sep; 27(9):803-12. PubMed ID: 23543344
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
6. Treatment of spasticity with botulinum toxin.
O'Brien CF
Clin J Pain; 2002; 18(6 Suppl):S182-90. PubMed ID: 12569967
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin in treating spasticity.
Das TK; Park DM
Br J Clin Pract; 1989 Nov; 43(11):401-3. PubMed ID: 2611094
[TBL] [Abstract][Full Text] [Related]
8. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
[TBL] [Abstract][Full Text] [Related]
9. Treatment of spasticity with botulinum toxin: a double-blind study.
Snow BJ; Tsui JK; Bhatt MH; Varelas M; Hashimoto SA; Calne DB
Ann Neurol; 1990 Oct; 28(4):512-5. PubMed ID: 2252363
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of spasticity with botulinum toxin].
Kerty E; Stien R
Tidsskr Nor Laegeforen; 1997 May; 117(14):2022-4. PubMed ID: 9235678
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
Davidson BJ; Ludlow CL
Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
[TBL] [Abstract][Full Text] [Related]
12. Effect of treatment with botulinum toxin on spasticity.
Das TK; Park DM
Postgrad Med J; 1989 Apr; 65(762):208-10. PubMed ID: 2594595
[TBL] [Abstract][Full Text] [Related]
13. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients.
Hesse S; Krajnik J; Luecke D; Jahnke MT; Gregoric M; Mauritz KH
Stroke; 1996 Mar; 27(3):455-60. PubMed ID: 8610313
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
Fève A; Decq P; Filipetti P; Kéravel Y
Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hip adductor spasticity with botulinum toxin type B].
Oechsner M
Nervenarzt; 2002 Dec; 73(12):1179-82. PubMed ID: 12486568
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
[TBL] [Abstract][Full Text] [Related]
18. The effect of neural lesion type on botulinum toxin dosage: a retrospective chart review.
Phadke CP; Davidson C; Ismail F; Boulias C
PM R; 2014 May; 6(5):406-11. PubMed ID: 24211697
[TBL] [Abstract][Full Text] [Related]
19. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
Tilton AH
J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
[TBL] [Abstract][Full Text] [Related]
20. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
Teasell R; Foley N; Pereira S; Sequeira K; Miller T
Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
